Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jasmine L. Hamilton"'
Autor:
Jasmine L Hamilton, Azadeh Hatef, Muhammad Imran ul-Haq, Neelima Nair, Suraj Unniappan, Jayachandran N Kizhakkedathu
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e109880 (2014)
Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each
Externí odkaz:
https://doaj.org/article/a61afbb7a0284a7c94dce51a038b07d1
Autor:
Jayachandran N. Kizhakkedathu, Jasmine L. Hamilton, Urs O. Häfeli, Vesna Sossi, Paul Schaffer, Rajesh A. Shenoi, Katayoun Saatchi, Cristina Rodríguez-Rodríguez, Veronika Schmitt
Publikováno v:
RSC Advances. 8:5586-5595
Polymeric nanocarriers are promising entities for cancer diagnosis and therapy. The aim of such nanocarriers is to selectively accumulate in cancerous tissue that is difficult to visualize or treat. The passive accumulation of a nanocarrier in a tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e9f67b064c3379612b8ac63283fe7ea
https://doi.org/10.1039/c7ra09183d
https://doi.org/10.1039/c7ra09183d
Autor:
Jasmine L. Hamilton, Fei-Fei Liu, Mazaheer Bana, Veng Chhin, Jerry Roussos, Sophie Foxcroft, Terry Michaelson, Andrea Bezjak
Publikováno v:
JCO clinical cancer informatics. 1
Purpose This study reports on the implementation of an electronic consent-to-treatment system (e-Consent) in a busy radiation medicine program and compares it with the previous paper-based method of documenting patient consent. Methods A password-pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9dc5b1abc4353f52717f65b8f2528e3
https://pubmed.ncbi.nlm.nih.gov/30657388
https://pubmed.ncbi.nlm.nih.gov/30657388
Autor:
Sophie Foxcroft, C. Lam, Andrea Bezjak, Jasmine L. Hamilton, J. Cooke-Lauder, Elen Moyo, P. Zahedi, Raimond Wong, Tara Spence, Michael Milosevic, Daniel Letourneau, Richard W. Tsang, Fei-Fei Liu, David A. Jaffray
Publikováno v:
Current Oncology
Volume 24
Issue 6
Pages 3725-523
Volume 24
Issue 6
Pages 3725-523
Background: In this paper, we report on the process of strategic planning in the Radiation Medicine Program (RMP) at the Princess Margaret Cancer Centre. The RMP conducted a strategic planning exercise to ensure that program priorities reflect the cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::825cb091295bfd8a962b740700e6e881
Autor:
Jayachandran N. Kizhakkedathu, Rajesh A. Shenoi, Sonja Horte, Jasmine L. Hamilton, Benjamin F.L. Lai, Iren Constantinescu, Heather A. Leitch, Muhammad Imran ul-haq
Publikováno v:
ACS Nano. 7:10704-10716
Patients requiring chronic red blood cell (RBC) transfusions for inherited or acquired anemias are at risk of developing transfusional iron overload, which may impact negatively on organ function and survival. Current iron chelators are suboptimal du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a11eb3f6eb4c13e2c1bda2c265fdd61
https://doi.org/10.1021/nn4035074
https://doi.org/10.1021/nn4035074
Autor:
Muhammad Imran ul-haq, Jasmine L. Hamilton, A. Louise Creagh, Jayachandran N. Kizhakkedathu, Charles A. Haynes
Publikováno v:
Macromolecular bioscience. 17(3)
Desferrioxamine (DFO) is a clinically approved, high affinity iron chelator used for the treatment of iron overload. Due to its short half-life and toxicity, DFO is administered for 8-12 h per day, 5-7 d per week. In this manuscript, the influence of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54a80c8829ce26776bb055baf1c10864
https://pubmed.ncbi.nlm.nih.gov/27683190
https://pubmed.ncbi.nlm.nih.gov/27683190
Autor:
Jasmine L. Hamilton, Azadeh Hatef, Benjamin F.L. Lai, Srinivas Abbina, Manu Thomas Kalathottukaren, Suraj Unniappan, Muhammad Imran ul-haq, Jayachandran N. Kizhakkedathu
Publikováno v:
Biomaterials. 102
Desferrioxamine (DFO) is currently in clinical use to remove iron from transfusion-dependent patients with β-thalassemia major, sickle-cell anemia and the myelodysplastic syndromes. However, its short half-life, burdensome, subcutaneous mode of admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1d69e13460ad084f193fbca71a797d
https://pubmed.ncbi.nlm.nih.gov/27322959
https://pubmed.ncbi.nlm.nih.gov/27322959
Autor:
Jasmine L. Hamilton, Jayaprakash K. Narayanannair, Rajesh K. Kainthan, Sonja Horte, Benjamin F.L. Lai, Jos P. Varghese, Jayachandran N. Kizhakkedathu, Rajesh A. Shenoi, Muthiah Manoharan, Kallanthottathil G. Rajeev
Publikováno v:
Journal of the American Chemical Society. 134:14945-14957
Multifunctional biocompatible and biodegradable nanomaterials incorporating specific degradable linkages that respond to various stimuli and with defined degradation profiles are critical to the advancement of targeted nanomedicine. Herein we report,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5269f30de39e413e3ee90b2160a52f1a
https://doi.org/10.1021/ja305080f
https://doi.org/10.1021/ja305080f
Publikováno v:
Molecular and cellular therapies
Desferrioxamine (DFO), deferiprone (L1) and desferasirox (ICL-670) are clinically approved iron chelators used to treat secondary iron overload. Although iron chelators have been utilized since the 1960s and there has been much improvement in availab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c3d42c0df902201c88bc03dfeaa72f7
https://doi.org/10.1186/s40591-015-0039-1
https://doi.org/10.1186/s40591-015-0039-1
Autor:
Jayachandran N. Kizhakkedathu, Neelima Nair, Jasmine L. Hamilton, Azadeh Hatef, Muhammad Imran ul-haq, Suraj Unniappan
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 10, p e109880 (2014)
PLoS ONE, Vol 9, Iss 10, p e109880 (2014)
Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox or L1) are the current standard of care for the treatment of iron overload. Although each
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f06d28705c538dd54f0371ed5bbdbda
https://pubmed.ncbi.nlm.nih.gov/25329065
https://pubmed.ncbi.nlm.nih.gov/25329065